TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 18, No. 14 July 18, 2012
__________________________________________________________
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None Submitted for this issue.
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
ABOUT TRIGGER
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 18, No. 14 July 18, 2012
(The next issue will be on August 1, 2012)
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None Submitted for this issue.
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/10u9p3a3jWhiogZU87z6KNw/
Adams M (2012) Tissue factor pathway inhibitor: new insights into an old inhibitor. Semin Thromb Hemost 38:129-134.
http://www.ncbi.nlm.nih.gov/pubmed/22422327
Agerso H, Tranholm M (2012) Pharmacokinetics and pharmacodynamics of rFVIIa and new improved bypassing agents for the treatment of haemophilia. Haemophilia 18 Suppl 5:6-10.
http://www.ncbi.nlm.nih.gov/pubmed/22757678
Albayrak M, Gursel T, Kaya Z, Kocak U (2012) Alterations in Procoagulant, Anticoagulant, and Fibrinolytic Systems Before and After Start of Induction Chemotherapy in Children With Acute Lymphoblastic Leukemia. Clin Appl Thromb Hemost.
http://www.ncbi.nlm.nih.gov/pubmed/22751908
Arderiu G, Pena E, Aledo R, Badimon L (2012) Tissue factor-akt signaling triggers microvessel formation. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/22784289
Banerjee A, Blois SL, Wood RD (2011) Comparing citrated native, kaolin-activated, and tissue factor-activated samples and determining intraindividual variability for feline thromboelastography. J Vet Diagn Invest 23:1109-1113.
http://www.ncbi.nlm.nih.gov/pubmed/22362790
Bladbjerg EM, Henriksen JE, Akram S, Gram J (2012) Effects of mealtime insulin aspart and bedtime neutral protamine Hagedorn insulin on postprandial coagulation and fibrinolysis in patients with type 2 diabetes. Diabetes Obes Metab 14:447-453.
http://www.ncbi.nlm.nih.gov/pubmed/22151836
Bouchard BA, Krudysz-Amblo J, Butenas S (2012) Platelet tissue factor is not expressed transiently after platelet activation. Blood 119:4338-4339; author reply 4339-4341.
http://www.ncbi.nlm.nih.gov/pubmed/22555664
Chambers RC, Scotton CJ (2012) Coagulation cascade proteinases in lung injury and fibrosis. Proc Am Thorac Soc 9:96-101.
http://www.ncbi.nlm.nih.gov/pubmed/22802281
Colace TV, Muthard RW, Diamond SL (2012) Thrombus growth and embolism on tissue factor-bearing collagen surfaces under flow: role of thrombin with and without fibrin. Arterioscler Thromb Vasc Biol 32:1466-1476.
http://www.ncbi.nlm.nih.gov/pubmed/22516070
Delabranche X, Berger A, Boisrame-Helms J, Meziani F (2012) Microparticles and infectious diseases. Med Mal Infect.
http://www.ncbi.nlm.nih.gov/pubmed/22766273
Duman EN, Saylan S, Cekic B (2012) Perioperative Management of a Pediatric Patient with Glanzmann's Thrombasthenia during Adenoidectomy. Rev Bras Anestesiol 62:548-553.
http://www.ncbi.nlm.nih.gov/pubmed/22793971
Elmer J, Wittels KA (2012) Emergency reversal of pentasaccharide anticoagulants: a systematic review of the literature. Transfus Med 22:108-115.
http://www.ncbi.nlm.nih.gov/pubmed/22171588
Giordano P, Lassandro G, Tesse R, Longo S, Valente F, Cappiello AR, Coppola A (2012) Innovative use of recombinant activated factor VII during physical rehabilitation in an Italian child with Glanzmann's thromboasthenia. Blood Transfus:1-3.
http://www.ncbi.nlm.nih.gov/pubmed/22790269
Girolami A, Vettore S, Ruzzon E, Marinis GB, Fabris F (2012) Rare and unusual bleeding manifestations in congenital bleeding disorders: an annotated review. Clin Appl Thromb Hemost 18:121-127.
http://www.ncbi.nlm.nih.gov/pubmed/21873355
Hsue PY, Scherzer R, Grunfeld C, Nordstrom SM, Schnell A, Kohl LP, . . . Weiss EJ (2012) HIV infection is associated with decreased thrombin generation. Clin Infect Dis 54:1196-1203.
http://www.ncbi.nlm.nih.gov/pubmed/22438347
Huang ZJ, Wang R, Liu ZZ, Wang SY, Yan JH, Luo Q (2012) [Humanized monoclonal antibody TNT-3-mediated truncated tissue factor for the treatment of H(22) hepatoma-bearing mice]. Zhonghua Zhong Liu Za Zhi 34:249-253.
http://www.ncbi.nlm.nih.gov/pubmed/22781034
Jayaraman M, Ansell SM, Mui BL, Tam YK, Chen J, Du X, . . . Hope MJ (2012) Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo. Angew Chem Int Ed Engl.
http://www.ncbi.nlm.nih.gov/pubmed/22782619
Jia ZC, Wan YL, Tang JQ, Dai Y, Liu YC, Wang X, Zhu J (2012) Tissue factor/activated factor VIIa induces matrix metalloproteinase-7 expression through activation of c-Fos via ERK1/2 and p38 MAPK signaling pathways in human colon cancer cell. Int J Colorectal Dis 27:437-445.
http://www.ncbi.nlm.nih.gov/pubmed/22076613
Johansson PI, Sorensen AM, Perner A, Welling KL, Wanscher M, Larsen CF, Ostrowski SR (2012) Elderly trauma patients have high circulating noradrenaline levels but attenuated release of adrenaline, platelets, and leukocytes in response to increasing injury severity. Crit Care Med 40:1844-1850.
http://www.ncbi.nlm.nih.gov/pubmed/22610188
Karkouti K, Levy JH (2011) Commentary: recombinant activated factor VII: the controversial conundrum regarding its off-label use. Anesth Analg 113:711-712.
http://www.ncbi.nlm.nih.gov/pubmed/21788315
Katgi A, Ataca P, Kahraman S, Piskin O, Ozcan MA, Demirkan F, . . . Undar B (2012) Ischemic stroke after recombinant factor VIIa treatment in acquired hemophilia A patient. Blood Coagul Fibrinolysis 23:69-70.
http://www.ncbi.nlm.nih.gov/pubmed/22123285
Koh YR, Cho SJ, Yeom SR, Chang CL, Lee EY, Son HC, Kim HH (2012) Evaluation of recombinant factor VIIa treatment for massive hemorrhage in patients with multiple traumas. Ann Lab Med 32:145-152.
http://www.ncbi.nlm.nih.gov/pubmed/22389882
Kruthika-Vinod TP, Nagaraja D, Christopher R (2012) Coagulation factor VII R353Q polymorphism and the risk of puerperal cerebral venous thrombosis. J Clin Neurosci 19:190-191.
http://www.ncbi.nlm.nih.gov/pubmed/22136731
Lee R, Williams JC, Mackman N (2012) P2X7 Regulation of Macrophage Tissue Factor Activity and Microparticle Generation. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/22759201
Levi M, van der Poll T, Schultz M (2012) New insights into pathways that determine the link between infection and thrombosis. Neth J Med 70:114-120.
http://www.ncbi.nlm.nih.gov/pubmed/22516575
Li S, Zhang S, Li N, Li Z, Yu B, Tian Y (2012) Arterial smooth muscle injury causes blood tissue factor elevation predicting restenosis after pci. Scand Cardiovasc J 46:87-92.
http://www.ncbi.nlm.nih.gov/pubmed/22204555
Lindstrom OK, Tukiainen EM, Kylanpaa ML, Mentula PJ, Puolakkainen PA, Wartiovaara-Kautto UM, . . . Petaja JM (2011) Thrombin generation in vitro and in vivo, and disturbed tissue factor regulation in patients with acute pancreatitis. Pancreatology 11:557-566.
http://www.ncbi.nlm.nih.gov/pubmed/22213026
Liotta EM, Garg RK, Temes RE, John S, Lee VH, Bleck TP, Prabhakaran S (2012) Warfarin-Associated Intracerebral Hemorrhage Is Inadequately Treated at Community Emergency Departments. Stroke.
http://www.ncbi.nlm.nih.gov/pubmed/22773555
Lippi G, Favaloro EJ (2012) Coagulopathies and thrombosis: usual and unusual causes and associations, part VI. Semin Thromb Hemost 38:125-128.
http://www.ncbi.nlm.nih.gov/pubmed/22422326
Lippi G, Favaloro EJ, Cervellin G (2012) Hemostatic properties of the lymph: relationships with occlusion and thrombosis. Semin Thromb Hemost 38:213-221.
http://www.ncbi.nlm.nih.gov/pubmed/22422335
Lison S, Dietrich W, Spannagl M (2012) Review article: unexpected bleeding in the operating room: the role of acquired von Willebrand disease. Anesth Analg 114:73-81.
http://www.ncbi.nlm.nih.gov/pubmed/22025497
Liu ZL, Yang L, Liu MM, Bai O, Cui JW, Li PT, Li W (2012) [Clinical analysis of recombinant activated factor VIIa for 18 patients with severe bleeding]. Zhonghua Xue Ye Xue Za Zhi 33:409-411.
http://www.ncbi.nlm.nih.gov/pubmed/22781803
Lorente L, Martin MM, Varo N, Borreguero-Leon JM, Sole-Violan J, Blanquer J, . . . Paramo JA (2011) Association between serum soluble CD40 ligand levels and mortality in patients with severe sepsis. Crit Care 15:R97.
http://www.ncbi.nlm.nih.gov/pubmed/21406105
Mackman N (2012) New insights into the mechanisms of venous thrombosis. J Clin Invest 122:2331-2336.
http://www.ncbi.nlm.nih.gov/pubmed/22751108
Mandal SK, Sagar G, Sahoo M, Jasuja S (2012) Recombinant activated factor VII for diffuse alveolar hemorrhage in microscopic polyangiitis. Indian J Nephrol 22:130-132.
http://www.ncbi.nlm.nih.gov/pubmed/22787316
Martin E, Cevik C, Nugent K (2012) The role of hypervirulent Staphylococcus aureus infections in the development of deep vein thrombosis. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/22771217
Miesbach W, Seifried E (2012) New direct oral anticoagulants - current therapeutic options and treatment recommendations for bleeding complications. Thromb Haemost 108.
http://www.ncbi.nlm.nih.gov/pubmed/22782297
Monroe DM, Hoffman M (2012) The clotting system - a major player in wound healing. Haemophilia 18 Suppl 5:11-16.
http://www.ncbi.nlm.nih.gov/pubmed/22757679
Morel N, Chabarttier C, Merson L, Lelias A, Bernard JC, Delaunay F, . . . Janvier G (2012) Advantage of using a recombinant activated factor VII in traumatic haemorrhagic shock: The Bordeaux experience. J Emerg Trauma Shock 5:143-148.
http://www.ncbi.nlm.nih.gov/pubmed/22787344
Morrissey JH (2012) The many domains of TFPI. Thromb Haemost 108.
http://www.ncbi.nlm.nih.gov/pubmed/22782428
Neal MD, Marsh A, Marino R, Kautza B, Raval JS, Forsythe RM, . . . Sperry JL (2012) Massive transfusion: an evidence-based review of recent developments. Arch Surg 147:563-571.
http://www.ncbi.nlm.nih.gov/pubmed/22786545
Oku K, Amengual O, Atsumi T (2012) Pathophysiology of thrombosis and pregnancy morbidity in the antiphospholipid syndrome. Eur J Clin Invest.
http://www.ncbi.nlm.nih.gov/pubmed/22784367
Oliveira DG, Alvarez-Flores MP, Lopes AR, Chudzinski-Tavassi AM (2012) Functional characterisation of Vizottin, the first factor Xa inhibitor purified from the leech Haementeria vizottoi. Thromb Haemost 108.
http://www.ncbi.nlm.nih.gov/pubmed/22782262
Pedersen A, Hanson E, Olsson S, Stanne TM, Blomstrand C, Melander O, . . . Jern C (2012) TFPI gene variation and ischemic stroke. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/22749962
Pettersen AA, Arnesen H, Opstad TB, Bratseth V, Seljeflot I (2012) Markers of endothelial and platelet activation are associated with high on-aspirin platelet reactivity in patients with stable coronary artery disease. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/22795340
Pirzer R, Elmas E, Haghi D, Lippert C, Kralev S, Lang S, . . . Kalsch T (2012) Platelet and monocyte activity markers and mediators of inflammation in Takotsubo cardiomyopathy. Heart Vessels 27:186-192.
http://www.ncbi.nlm.nih.gov/pubmed/21416113
Robak M, Trelinski J, Chojnowski K (2012) Hemostatic changes after 1 month of thalidomide and dexamethasone therapy in patients with multiple myeloma. Med Oncol.
http://www.ncbi.nlm.nih.gov/pubmed/22772968
Roumenina LT, Frimat M, Miller EC, Provot F, Dragon-Durey MA, Bordereau P, . . . Fremeaux-Bacchi V (2012) A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function. Blood 119:4182-4191.
http://www.ncbi.nlm.nih.gov/pubmed/22246034
Sanborn MR, Thom SR, Bohman LE, Stein SC, Levine JM, Milovanova T, . . . Kumar MA (2012) Temporal dynamics of microparticle elevation following subarachnoid hemorrhage. J Neurosurg.
http://www.ncbi.nlm.nih.gov/pubmed/22794324
Sasaki T, Yoshimoto N, Sugimoto K, Takada K, Murayama N, Yamazaki H, . . . Ishii H (2012) Intravenous and oral administrations of DD2 [7-Amino-2-(sulfanylmethyl)heptanoic acid] produce thrombolysis through inhibition of plasma TAFIa in rats with tissue factor-induced microthrombosis. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/22795218
Sborov DW, Rodgers GM (2012) Acquired hemophilia a: a current review of autoantibody disease. Clin Adv Hematol Oncol 10:19-27.
http://www.ncbi.nlm.nih.gov/pubmed/22398803
Skolnick BE, Shenouda M, Khutoryansky NM, Pusateri AE, Gabriel D, Carr ME (2011) Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. Anesth Analg 113:703-710.
http://www.ncbi.nlm.nih.gov/pubmed/21890888
Smith JE, Fawcett R, Randalls B (2012) The use of recombinant activated factor VII in a patient with penetrating chest trauma and ongoing pulmonary hemorrhage. Mil Med 177:614-616.
http://www.ncbi.nlm.nih.gov/pubmed/22645892
Sokolov A, Hellerud BC, Johannessen EA, Mollnes TE (2012) Inflammatory response induced by candidate biomaterials of an implantable microfabricated sensor. J Biomed Mater Res A 100:1142-1150.
http://www.ncbi.nlm.nih.gov/pubmed/22337626
Stephan F, Aarden LA, Zeerleder S (2012) FSAP, a new player in inflammation? Hamostaseologie 32:51-55.
http://www.ncbi.nlm.nih.gov/pubmed/22252569
Tatsumi K, Ohashi K, Tateno C, Yoshizato K, Yoshioka A, Shima M, Okano T (2012) Human hepatocyte propagation system in the mouse livers: functional maintenance of the production of coagulation and anticoagulation factors. Cell Transplant 21:437-445.
http://www.ncbi.nlm.nih.gov/pubmed/22793051
Tobin JM, Varon AJ (2012) Update in Trauma Anesthesiology: Perioperative Resuscitation Management. Anesth Analg.
http://www.ncbi.nlm.nih.gov/pubmed/22763906
Van den Hengel LG, Osanto S, Reitsma PH, Versteeg H (2012) Murine tissue factor coagulant activity is critically dependent on the presence of an intact allosteric disulfide. Haematologica.
http://www.ncbi.nlm.nih.gov/pubmed/22801966
Winch PD, Naguib AN, Bradshaw JR, Galantowicz M, Tobias JD (2012) Decreasing the Need for Transfusion: Infant Cardiac Surgery Using Hemodilution and Recombinant Factor VIIa. Pediatr Cardiol.
http://www.ncbi.nlm.nih.gov/pubmed/22760694
Wygrecka M, Zakrzewicz D, Taborski B, Didiasova M, Kwapiszewska G, Preissner KT, Markart P (2012) TGF-beta1 Induces Tissue Factor Expression in Human Lung Fibroblasts in a PI3K/JNK/Akt- and AP-1-Dependent Manner. Am J Respir Cell Mol Biol.
http://www.ncbi.nlm.nih.gov/pubmed/22771387
Yin W, Sheng J (2012) [Progress in relationship between heritable hypercoagulable state and avascular necrosis of femoral head]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 26:695-698.
http://www.ncbi.nlm.nih.gov/pubmed/22792766
Zhang J, Yang S, Xie Y, Chen X, Zhao Y, He D, Li J (2012) Detection of methylated tissue factor pathway inhibitor 2 and human long DNA in fecal samples of patients with colorectal cancer in China. Cancer Epidemiol 36:73-77.
http://www.ncbi.nlm.nih.gov/pubmed/21621497
Zhang Q, Liu XJ, Hu L, Liao DS, Zheng YB, Zhen YS, Song X (2012) Factor VII light chain-targeted lidamycin targets tissue factor-overexpressing tumor cells for cancer therapy. Int J Mol Med 29:409-415.
http://www.ncbi.nlm.nih.gov/pubmed/22108624
Zhou Q, Huang T, Wang YF, Zhou XB, Liang LJ, Peng BG (2011) Role of tissue factor in hepatocellular carcinoma genesis, invasion and metastasis. Chin Med J (Engl) 124:3746-3751.
http://www.ncbi.nlm.nih.gov/pubmed/22340235
__________________________________________________________
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/10u9p3a3jWhiogZU87z6KNw/
Adams M (2012) Tissue factor pathway inhibitor: new insights into an old inhibitor. Semin Thromb Hemost 38:129-134.
http://www.ncbi.nlm.nih.gov/pubmed/22422327
Agerso H, Tranholm M (2012) Pharmacokinetics and pharmacodynamics of rFVIIa and new improved bypassing agents for the treatment of haemophilia. Haemophilia 18 Suppl 5:6-10.
http://www.ncbi.nlm.nih.gov/pubmed/22757678
Albayrak M, Gursel T, Kaya Z, Kocak U (2012) Alterations in Procoagulant, Anticoagulant, and Fibrinolytic Systems Before and After Start of Induction Chemotherapy in Children With Acute Lymphoblastic Leukemia. Clin Appl Thromb Hemost.
http://www.ncbi.nlm.nih.gov/pubmed/22751908
Arderiu G, Pena E, Aledo R, Badimon L (2012) Tissue factor-akt signaling triggers microvessel formation. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/22784289
Banerjee A, Blois SL, Wood RD (2011) Comparing citrated native, kaolin-activated, and tissue factor-activated samples and determining intraindividual variability for feline thromboelastography. J Vet Diagn Invest 23:1109-1113.
http://www.ncbi.nlm.nih.gov/pubmed/22362790
Bladbjerg EM, Henriksen JE, Akram S, Gram J (2012) Effects of mealtime insulin aspart and bedtime neutral protamine Hagedorn insulin on postprandial coagulation and fibrinolysis in patients with type 2 diabetes. Diabetes Obes Metab 14:447-453.
http://www.ncbi.nlm.nih.gov/pubmed/22151836
Bouchard BA, Krudysz-Amblo J, Butenas S (2012) Platelet tissue factor is not expressed transiently after platelet activation. Blood 119:4338-4339; author reply 4339-4341.
http://www.ncbi.nlm.nih.gov/pubmed/22555664
Chambers RC, Scotton CJ (2012) Coagulation cascade proteinases in lung injury and fibrosis. Proc Am Thorac Soc 9:96-101.
http://www.ncbi.nlm.nih.gov/pubmed/22802281
Colace TV, Muthard RW, Diamond SL (2012) Thrombus growth and embolism on tissue factor-bearing collagen surfaces under flow: role of thrombin with and without fibrin. Arterioscler Thromb Vasc Biol 32:1466-1476.
http://www.ncbi.nlm.nih.gov/pubmed/22516070
Delabranche X, Berger A, Boisrame-Helms J, Meziani F (2012) Microparticles and infectious diseases. Med Mal Infect.
http://www.ncbi.nlm.nih.gov/pubmed/22766273
Duman EN, Saylan S, Cekic B (2012) Perioperative Management of a Pediatric Patient with Glanzmann's Thrombasthenia during Adenoidectomy. Rev Bras Anestesiol 62:548-553.
http://www.ncbi.nlm.nih.gov/pubmed/22793971
Elmer J, Wittels KA (2012) Emergency reversal of pentasaccharide anticoagulants: a systematic review of the literature. Transfus Med 22:108-115.
http://www.ncbi.nlm.nih.gov/pubmed/22171588
Giordano P, Lassandro G, Tesse R, Longo S, Valente F, Cappiello AR, Coppola A (2012) Innovative use of recombinant activated factor VII during physical rehabilitation in an Italian child with Glanzmann's thromboasthenia. Blood Transfus:1-3.
http://www.ncbi.nlm.nih.gov/pubmed/22790269
Girolami A, Vettore S, Ruzzon E, Marinis GB, Fabris F (2012) Rare and unusual bleeding manifestations in congenital bleeding disorders: an annotated review. Clin Appl Thromb Hemost 18:121-127.
http://www.ncbi.nlm.nih.gov/pubmed/21873355
Hsue PY, Scherzer R, Grunfeld C, Nordstrom SM, Schnell A, Kohl LP, . . . Weiss EJ (2012) HIV infection is associated with decreased thrombin generation. Clin Infect Dis 54:1196-1203.
http://www.ncbi.nlm.nih.gov/pubmed/22438347
Huang ZJ, Wang R, Liu ZZ, Wang SY, Yan JH, Luo Q (2012) [Humanized monoclonal antibody TNT-3-mediated truncated tissue factor for the treatment of H(22) hepatoma-bearing mice]. Zhonghua Zhong Liu Za Zhi 34:249-253.
http://www.ncbi.nlm.nih.gov/pubmed/22781034
Jayaraman M, Ansell SM, Mui BL, Tam YK, Chen J, Du X, . . . Hope MJ (2012) Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo. Angew Chem Int Ed Engl.
http://www.ncbi.nlm.nih.gov/pubmed/22782619
Jia ZC, Wan YL, Tang JQ, Dai Y, Liu YC, Wang X, Zhu J (2012) Tissue factor/activated factor VIIa induces matrix metalloproteinase-7 expression through activation of c-Fos via ERK1/2 and p38 MAPK signaling pathways in human colon cancer cell. Int J Colorectal Dis 27:437-445.
http://www.ncbi.nlm.nih.gov/pubmed/22076613
Johansson PI, Sorensen AM, Perner A, Welling KL, Wanscher M, Larsen CF, Ostrowski SR (2012) Elderly trauma patients have high circulating noradrenaline levels but attenuated release of adrenaline, platelets, and leukocytes in response to increasing injury severity. Crit Care Med 40:1844-1850.
http://www.ncbi.nlm.nih.gov/pubmed/22610188
Karkouti K, Levy JH (2011) Commentary: recombinant activated factor VII: the controversial conundrum regarding its off-label use. Anesth Analg 113:711-712.
http://www.ncbi.nlm.nih.gov/pubmed/21788315
Katgi A, Ataca P, Kahraman S, Piskin O, Ozcan MA, Demirkan F, . . . Undar B (2012) Ischemic stroke after recombinant factor VIIa treatment in acquired hemophilia A patient. Blood Coagul Fibrinolysis 23:69-70.
http://www.ncbi.nlm.nih.gov/pubmed/22123285
Koh YR, Cho SJ, Yeom SR, Chang CL, Lee EY, Son HC, Kim HH (2012) Evaluation of recombinant factor VIIa treatment for massive hemorrhage in patients with multiple traumas. Ann Lab Med 32:145-152.
http://www.ncbi.nlm.nih.gov/pubmed/22389882
Kruthika-Vinod TP, Nagaraja D, Christopher R (2012) Coagulation factor VII R353Q polymorphism and the risk of puerperal cerebral venous thrombosis. J Clin Neurosci 19:190-191.
http://www.ncbi.nlm.nih.gov/pubmed/22136731
Lee R, Williams JC, Mackman N (2012) P2X7 Regulation of Macrophage Tissue Factor Activity and Microparticle Generation. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/22759201
Levi M, van der Poll T, Schultz M (2012) New insights into pathways that determine the link between infection and thrombosis. Neth J Med 70:114-120.
http://www.ncbi.nlm.nih.gov/pubmed/22516575
Li S, Zhang S, Li N, Li Z, Yu B, Tian Y (2012) Arterial smooth muscle injury causes blood tissue factor elevation predicting restenosis after pci. Scand Cardiovasc J 46:87-92.
http://www.ncbi.nlm.nih.gov/pubmed/22204555
Lindstrom OK, Tukiainen EM, Kylanpaa ML, Mentula PJ, Puolakkainen PA, Wartiovaara-Kautto UM, . . . Petaja JM (2011) Thrombin generation in vitro and in vivo, and disturbed tissue factor regulation in patients with acute pancreatitis. Pancreatology 11:557-566.
http://www.ncbi.nlm.nih.gov/pubmed/22213026
Liotta EM, Garg RK, Temes RE, John S, Lee VH, Bleck TP, Prabhakaran S (2012) Warfarin-Associated Intracerebral Hemorrhage Is Inadequately Treated at Community Emergency Departments. Stroke.
http://www.ncbi.nlm.nih.gov/pubmed/22773555
Lippi G, Favaloro EJ (2012) Coagulopathies and thrombosis: usual and unusual causes and associations, part VI. Semin Thromb Hemost 38:125-128.
http://www.ncbi.nlm.nih.gov/pubmed/22422326
Lippi G, Favaloro EJ, Cervellin G (2012) Hemostatic properties of the lymph: relationships with occlusion and thrombosis. Semin Thromb Hemost 38:213-221.
http://www.ncbi.nlm.nih.gov/pubmed/22422335
Lison S, Dietrich W, Spannagl M (2012) Review article: unexpected bleeding in the operating room: the role of acquired von Willebrand disease. Anesth Analg 114:73-81.
http://www.ncbi.nlm.nih.gov/pubmed/22025497
Liu ZL, Yang L, Liu MM, Bai O, Cui JW, Li PT, Li W (2012) [Clinical analysis of recombinant activated factor VIIa for 18 patients with severe bleeding]. Zhonghua Xue Ye Xue Za Zhi 33:409-411.
http://www.ncbi.nlm.nih.gov/pubmed/22781803
Lorente L, Martin MM, Varo N, Borreguero-Leon JM, Sole-Violan J, Blanquer J, . . . Paramo JA (2011) Association between serum soluble CD40 ligand levels and mortality in patients with severe sepsis. Crit Care 15:R97.
http://www.ncbi.nlm.nih.gov/pubmed/21406105
Mackman N (2012) New insights into the mechanisms of venous thrombosis. J Clin Invest 122:2331-2336.
http://www.ncbi.nlm.nih.gov/pubmed/22751108
Mandal SK, Sagar G, Sahoo M, Jasuja S (2012) Recombinant activated factor VII for diffuse alveolar hemorrhage in microscopic polyangiitis. Indian J Nephrol 22:130-132.
http://www.ncbi.nlm.nih.gov/pubmed/22787316
Martin E, Cevik C, Nugent K (2012) The role of hypervirulent Staphylococcus aureus infections in the development of deep vein thrombosis. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/22771217
Miesbach W, Seifried E (2012) New direct oral anticoagulants - current therapeutic options and treatment recommendations for bleeding complications. Thromb Haemost 108.
http://www.ncbi.nlm.nih.gov/pubmed/22782297
Monroe DM, Hoffman M (2012) The clotting system - a major player in wound healing. Haemophilia 18 Suppl 5:11-16.
http://www.ncbi.nlm.nih.gov/pubmed/22757679
Morel N, Chabarttier C, Merson L, Lelias A, Bernard JC, Delaunay F, . . . Janvier G (2012) Advantage of using a recombinant activated factor VII in traumatic haemorrhagic shock: The Bordeaux experience. J Emerg Trauma Shock 5:143-148.
http://www.ncbi.nlm.nih.gov/pubmed/22787344
Morrissey JH (2012) The many domains of TFPI. Thromb Haemost 108.
http://www.ncbi.nlm.nih.gov/pubmed/22782428
Neal MD, Marsh A, Marino R, Kautza B, Raval JS, Forsythe RM, . . . Sperry JL (2012) Massive transfusion: an evidence-based review of recent developments. Arch Surg 147:563-571.
http://www.ncbi.nlm.nih.gov/pubmed/22786545
Oku K, Amengual O, Atsumi T (2012) Pathophysiology of thrombosis and pregnancy morbidity in the antiphospholipid syndrome. Eur J Clin Invest.
http://www.ncbi.nlm.nih.gov/pubmed/22784367
Oliveira DG, Alvarez-Flores MP, Lopes AR, Chudzinski-Tavassi AM (2012) Functional characterisation of Vizottin, the first factor Xa inhibitor purified from the leech Haementeria vizottoi. Thromb Haemost 108.
http://www.ncbi.nlm.nih.gov/pubmed/22782262
Pedersen A, Hanson E, Olsson S, Stanne TM, Blomstrand C, Melander O, . . . Jern C (2012) TFPI gene variation and ischemic stroke. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/22749962
Pettersen AA, Arnesen H, Opstad TB, Bratseth V, Seljeflot I (2012) Markers of endothelial and platelet activation are associated with high on-aspirin platelet reactivity in patients with stable coronary artery disease. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/22795340
Pirzer R, Elmas E, Haghi D, Lippert C, Kralev S, Lang S, . . . Kalsch T (2012) Platelet and monocyte activity markers and mediators of inflammation in Takotsubo cardiomyopathy. Heart Vessels 27:186-192.
http://www.ncbi.nlm.nih.gov/pubmed/21416113
Robak M, Trelinski J, Chojnowski K (2012) Hemostatic changes after 1 month of thalidomide and dexamethasone therapy in patients with multiple myeloma. Med Oncol.
http://www.ncbi.nlm.nih.gov/pubmed/22772968
Roumenina LT, Frimat M, Miller EC, Provot F, Dragon-Durey MA, Bordereau P, . . . Fremeaux-Bacchi V (2012) A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function. Blood 119:4182-4191.
http://www.ncbi.nlm.nih.gov/pubmed/22246034
Sanborn MR, Thom SR, Bohman LE, Stein SC, Levine JM, Milovanova T, . . . Kumar MA (2012) Temporal dynamics of microparticle elevation following subarachnoid hemorrhage. J Neurosurg.
http://www.ncbi.nlm.nih.gov/pubmed/22794324
Sasaki T, Yoshimoto N, Sugimoto K, Takada K, Murayama N, Yamazaki H, . . . Ishii H (2012) Intravenous and oral administrations of DD2 [7-Amino-2-(sulfanylmethyl)heptanoic acid] produce thrombolysis through inhibition of plasma TAFIa in rats with tissue factor-induced microthrombosis. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/22795218
Sborov DW, Rodgers GM (2012) Acquired hemophilia a: a current review of autoantibody disease. Clin Adv Hematol Oncol 10:19-27.
http://www.ncbi.nlm.nih.gov/pubmed/22398803
Skolnick BE, Shenouda M, Khutoryansky NM, Pusateri AE, Gabriel D, Carr ME (2011) Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. Anesth Analg 113:703-710.
http://www.ncbi.nlm.nih.gov/pubmed/21890888
Smith JE, Fawcett R, Randalls B (2012) The use of recombinant activated factor VII in a patient with penetrating chest trauma and ongoing pulmonary hemorrhage. Mil Med 177:614-616.
http://www.ncbi.nlm.nih.gov/pubmed/22645892
Sokolov A, Hellerud BC, Johannessen EA, Mollnes TE (2012) Inflammatory response induced by candidate biomaterials of an implantable microfabricated sensor. J Biomed Mater Res A 100:1142-1150.
http://www.ncbi.nlm.nih.gov/pubmed/22337626
Stephan F, Aarden LA, Zeerleder S (2012) FSAP, a new player in inflammation? Hamostaseologie 32:51-55.
http://www.ncbi.nlm.nih.gov/pubmed/22252569
Tatsumi K, Ohashi K, Tateno C, Yoshizato K, Yoshioka A, Shima M, Okano T (2012) Human hepatocyte propagation system in the mouse livers: functional maintenance of the production of coagulation and anticoagulation factors. Cell Transplant 21:437-445.
http://www.ncbi.nlm.nih.gov/pubmed/22793051
Tobin JM, Varon AJ (2012) Update in Trauma Anesthesiology: Perioperative Resuscitation Management. Anesth Analg.
http://www.ncbi.nlm.nih.gov/pubmed/22763906
Van den Hengel LG, Osanto S, Reitsma PH, Versteeg H (2012) Murine tissue factor coagulant activity is critically dependent on the presence of an intact allosteric disulfide. Haematologica.
http://www.ncbi.nlm.nih.gov/pubmed/22801966
Winch PD, Naguib AN, Bradshaw JR, Galantowicz M, Tobias JD (2012) Decreasing the Need for Transfusion: Infant Cardiac Surgery Using Hemodilution and Recombinant Factor VIIa. Pediatr Cardiol.
http://www.ncbi.nlm.nih.gov/pubmed/22760694
Wygrecka M, Zakrzewicz D, Taborski B, Didiasova M, Kwapiszewska G, Preissner KT, Markart P (2012) TGF-beta1 Induces Tissue Factor Expression in Human Lung Fibroblasts in a PI3K/JNK/Akt- and AP-1-Dependent Manner. Am J Respir Cell Mol Biol.
http://www.ncbi.nlm.nih.gov/pubmed/22771387
Yin W, Sheng J (2012) [Progress in relationship between heritable hypercoagulable state and avascular necrosis of femoral head]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 26:695-698.
http://www.ncbi.nlm.nih.gov/pubmed/22792766
Zhang J, Yang S, Xie Y, Chen X, Zhao Y, He D, Li J (2012) Detection of methylated tissue factor pathway inhibitor 2 and human long DNA in fecal samples of patients with colorectal cancer in China. Cancer Epidemiol 36:73-77.
http://www.ncbi.nlm.nih.gov/pubmed/21621497
Zhang Q, Liu XJ, Hu L, Liao DS, Zheng YB, Zhen YS, Song X (2012) Factor VII light chain-targeted lidamycin targets tissue factor-overexpressing tumor cells for cancer therapy. Int J Mol Med 29:409-415.
http://www.ncbi.nlm.nih.gov/pubmed/22108624
Zhou Q, Huang T, Wang YF, Zhou XB, Liang LJ, Peng BG (2011) Role of tissue factor in hepatocellular carcinoma genesis, invasion and metastasis. Chin Med J (Engl) 124:3746-3751.
http://www.ncbi.nlm.nih.gov/pubmed/22340235
__________________________________________________________
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
